國立高雄大學圖資館 |

Frontiers of COVID-19scientific and clinical aspects of the novel coronavirus 2019 /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Frontiers of COVID-19edited by Sasan Adibi ... [et al.].
Reminder of title:	scientific and clinical aspects of the novel coronavirus 2019 /
other author:	Adibi, Sasan.
Published:	Cham :Springer International Publishing :2022.
Description:	xx, 664 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	COVID-19 (Disease)
Online resource:	https://doi.org/10.1007/978-3-031-08045-6
ISBN:	9783031080456$q(electronic bk.)

Frontiers of COVID-19scientific and clinical aspects of the novel coronavirus 2019 /
Frontiers of COVID-19scientific and clinical aspects of the novel coronavirus 2019 /[electronic resource] :edited by Sasan Adibi ... [et al.]. - Cham :Springer International Publishing :2022. - xx, 664 p. :ill., digital ;24 cm.

Section I. History, Epidemiologic Background and Pathogenesis of Coronavirus -- Chapter 01: Surfaces as a source for SARS-CoV-2 transmission -- Chapter 02: Humoral immune response in SARS-CoV-2 infection & its therapeutic relevance -- Chapter 03: SARS-CoV-2 Invasion and Pathogenesis of COVID-19: A Perspective of viral receptors, bradykinin and purinergic system -- Chapter 04: Genetics and Biological characteristics of SARS-CoV-2 -- Chapter 05: COVID-19 impact on host at pathophysiological and cellular level -- Chapter 06: Identification of the COVID-19 droplet deposition path and its effects on the human respiratory tract before and after the disease: A scoping novel respiratory mask design -- Chapter 07: SARS-CoV-2 variants: Impact of Spike Mutations on Vaccine and Therapeutic strategies -- Chapter 08: Global biologic characteristics of Variants of Concern and Variants of Interest of SARS-CoV-2 -- Chapter 09: Emergence of COVID-19 variants and its global impact -- Section II. Clinical Observations -- Chapter 10: Psychological Impacts of the COVID-19 Pandemic -- Chapter 11: Spatial Epidemiology of COVID-19: Disease Risk, Prognosis, and Complications -- Chapter 12: Eye disorders and neuro-ophthalmic manifestations of COVID-19 -- Chapter 13: Evaluation and Management of Dysphagia during the COVID-19 Pandemic -- Chapter 14: Gastrointestinal Manifestations Of COVID-19, and Inflammatory Bowel Disease in the COVID-19 Era, Clinical Overview And Updated Guidelines -- Chapter 15: Post COVID-19 conditions-the new challenge to mankind -- Chapter 16: Association of Alpha 1 Antitrypsin deficiency with COVID-19 mortality: basis for clinical trials -- Chapter 17: Social cognition approaches to understanding and changing COVID-19 preventive behaviours -- Chapter 18: Neurological Complications of COVID-19 -- Chapter 19: The Impact of Covid-19 on Surgical Disease -- Section III. Interventions and Treatments -- Chapter 20: Pre-Hospital Management of COVID-19: Looking for a Future Perspective -- Chapter 21: Biotechnological strategies in the intervention and treatment of COVID-19 -- Chapter 22: Vitamin D: A Potential Prophylactic and Therapeutic Agent against COVID-19 -- Section IV. Current Trends and Future Directions -- Chapter 23: Rational repurposing of drugs, clinical trials candidates, and natural products for SARS-Cov-2 therapy -- Chapter 24: In Silico Drug Repositioning for COVID-19: Progress and Challenges -- Chapter 25: Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms -- Chapter 26: Different platforms, immune response modulators and challenges in SARS-CoV-2 vaccination -- Chapter 27: SARS-CoV-2 vaccine against virus: mission accomplished !? -- Chapter 28: COVID-19 vaccines authorized by stringent regulatory authorities and vaccine candidates expecting approval in 2021 -- Chapter 29: The Global Evolution of Clinical Practice During a Pandemic -- Chapter 30: Anticipated Long-Term Neurobehavioral Outcomes following COVID-19 -- Chapter 31. The road ahead.

This book aims to serve the critical interests of the global community by supplying the most current knowledge and understanding of Covid-19 epidemiology, treatment, and prognoses. There was much uncertain and contradictory information published in the first year of the novel coronavirus. The dynamics of COVID-19 have now been realized, including the type of antibodies produced in infected patients and their limited lasting endurance. This book will set the record straight on the concept of "herd immunity" and explore the current vaccine trials taking place in different countries. This comprehensive book will illuminate recent advances regarding COVID-19 and offer a possible roadmap on how to move forward. Frontiers of COVID-19: A Pathophysiology and Epidemiology Roadmap of Novel Coronavirus Disease will be a vital and forward-looking guide for infectious disease clinicians, scientists and researchers, and students at the graduate level.

ISBN: 9783031080456$q(electronic bk.)

Standard No.: 10.1007/978-3-031-08045-6doiSubjects--Topical Terms:

877725
COVID-19 (Disease)

LC Class. No.: RA664.C67 / F76 2022

Dewey Class. No.: 614.592414

Frontiers of COVID-19scientific and clinical aspects of the novel coronavirus 2019 /
LDR:05012nmm a2200325 a 4500 001 630719
003 DE-He213
005 20220908150327.0
006 m d
007 cr nn 008maaau
008 230329s2022 sz s 0 eng d
020 $a 9783031080456$q(electronic bk.)
020 $a 9783031080449$q(paper)
024 7 $a 10.1007/978-3-031-08045-6 $2 doi
035 $a 978-3-031-08045-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RA664.C67 $b F76 2022
072 7 $a MJ $2 bicssc
072 7 $a MED045000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 614.592414 $2 23
090 $a RA664.C67 $b F935 2022
245 0 0 $a Frontiers of COVID-19 $h [electronic resource] : $b scientific and clinical aspects of the novel coronavirus 2019 / $c edited by Sasan Adibi ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xx, 664 p. : $b ill., digital ; $c 24 cm.
505 0 $a Section I. History, Epidemiologic Background and Pathogenesis of Coronavirus -- Chapter 01: Surfaces as a source for SARS-CoV-2 transmission -- Chapter 02: Humoral immune response in SARS-CoV-2 infection & its therapeutic relevance -- Chapter 03: SARS-CoV-2 Invasion and Pathogenesis of COVID-19: A Perspective of viral receptors, bradykinin and purinergic system -- Chapter 04: Genetics and Biological characteristics of SARS-CoV-2 -- Chapter 05: COVID-19 impact on host at pathophysiological and cellular level -- Chapter 06: Identification of the COVID-19 droplet deposition path and its effects on the human respiratory tract before and after the disease: A scoping novel respiratory mask design -- Chapter 07: SARS-CoV-2 variants: Impact of Spike Mutations on Vaccine and Therapeutic strategies -- Chapter 08: Global biologic characteristics of Variants of Concern and Variants of Interest of SARS-CoV-2 -- Chapter 09: Emergence of COVID-19 variants and its global impact -- Section II. Clinical Observations -- Chapter 10: Psychological Impacts of the COVID-19 Pandemic -- Chapter 11: Spatial Epidemiology of COVID-19: Disease Risk, Prognosis, and Complications -- Chapter 12: Eye disorders and neuro-ophthalmic manifestations of COVID-19 -- Chapter 13: Evaluation and Management of Dysphagia during the COVID-19 Pandemic -- Chapter 14: Gastrointestinal Manifestations Of COVID-19, and Inflammatory Bowel Disease in the COVID-19 Era, Clinical Overview And Updated Guidelines -- Chapter 15: Post COVID-19 conditions-the new challenge to mankind -- Chapter 16: Association of Alpha 1 Antitrypsin deficiency with COVID-19 mortality: basis for clinical trials -- Chapter 17: Social cognition approaches to understanding and changing COVID-19 preventive behaviours -- Chapter 18: Neurological Complications of COVID-19 -- Chapter 19: The Impact of Covid-19 on Surgical Disease -- Section III. Interventions and Treatments -- Chapter 20: Pre-Hospital Management of COVID-19: Looking for a Future Perspective -- Chapter 21: Biotechnological strategies in the intervention and treatment of COVID-19 -- Chapter 22: Vitamin D: A Potential Prophylactic and Therapeutic Agent against COVID-19 -- Section IV. Current Trends and Future Directions -- Chapter 23: Rational repurposing of drugs, clinical trials candidates, and natural products for SARS-Cov-2 therapy -- Chapter 24: In Silico Drug Repositioning for COVID-19: Progress and Challenges -- Chapter 25: Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms -- Chapter 26: Different platforms, immune response modulators and challenges in SARS-CoV-2 vaccination -- Chapter 27: SARS-CoV-2 vaccine against virus: mission accomplished !? -- Chapter 28: COVID-19 vaccines authorized by stringent regulatory authorities and vaccine candidates expecting approval in 2021 -- Chapter 29: The Global Evolution of Clinical Practice During a Pandemic -- Chapter 30: Anticipated Long-Term Neurobehavioral Outcomes following COVID-19 -- Chapter 31. The road ahead.
520 $a This book aims to serve the critical interests of the global community by supplying the most current knowledge and understanding of Covid-19 epidemiology, treatment, and prognoses. There was much uncertain and contradictory information published in the first year of the novel coronavirus. The dynamics of COVID-19 have now been realized, including the type of antibodies produced in infected patients and their limited lasting endurance. This book will set the record straight on the concept of "herd immunity" and explore the current vaccine trials taking place in different countries. This comprehensive book will illuminate recent advances regarding COVID-19 and offer a possible roadmap on how to move forward. Frontiers of COVID-19: A Pathophysiology and Epidemiology Roadmap of Novel Coronavirus Disease will be a vital and forward-looking guide for infectious disease clinicians, scientists and researchers, and students at the graduate level.
650 0 $a COVID-19 (Disease) $3 877725
650 1 4 $a Internal Medicine. $3 273839
650 2 4 $a Diseases. $3 276053
700 1 $a Adibi, Sasan. $3 714198
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-08045-6
950 $a Medicine (SpringerNature-11650)